Title of Collaborative Activity: |
Targeting of Interleukin-13 Receptor a2 for Treatment of Head and Neck Squamous Cell Carcinoma Induced by Conditional Deletion of TGF-ß and PTEN Signaling |
Description of Collaborative Activity: |
The activity will test new animal models of head and neck squamous cell cancer with targeted treatments using Interleukin-13 Receptor alpha 2 antagonists. |
Type of Collaborative Activity: |
Research Initiative
|
Year the Collaborative Activity Originated: |
2010 |
NIH Participating Institutes/Centers/Office of the Director: |
NIDCD, NIDCR |
HHS Agency Collaborators on this Activity: |
FDA |
